IPO
NuvOx Therapeutics, Inc.
Filed with the SEC to go public on Jul 17, 2026. Newest amendment Oct 29, 2026.
Terms
| Price range | US$6.00 to US$8.00 a share | |
| Shares offered | 2,860,000 shares of common stock | |
| Offering size | US$17.2 million to US$22.9 million | Shares offered times the price range, worked out by 6ix |
| Underwriters' option | Up to 429,000 more shares | |
| Listing | NUOX on NYSE American | Intends to list |
| Underwriter | ThinkEquity |
From the cover of the amended prospectus (S-1/A) filed Oct 29, 2026
Steps
| Draft sent to the SEC in confidence | Dec 23, 2024 |
| Filed publicly | Jul 17, 2026 |
| Amended 3 times | Newest Oct 29, 2026 |
| Shares registered with an exchange | Not yet |
| Declared effective by the SEC | Not yet |
| Final prospectus, with the price | Not yet |
Filings
- Oct 29, 2026 S-1/A · Registration statement, amended
- Oct 13, 2026 S-1/A · Registration statement, amended
- Sep 16, 2026 S-1/A · Registration statement, amended
- Jul 17, 2026 S-1 · Registration statement
- May 6, 2025 DRS/A · Draft registration statement, amended
- Apr 8, 2025 DRS/A · Draft registration statement, amended
- Dec 23, 2024 DRS · Draft registration statement